Skip to Content

Signifor

In the US, Signifor (pasireotide systemic) is a member of the drug class somatostatin and somatostatin analogs and is used to treat Cushing's Syndrome.

US matches:

UK matches:

Ingredient matches for Signifor

Pasireotide

Pasireotide is reported as an ingredient of Signifor in the following countries:

  • Bosnia & Herzegowina
  • Canada
  • Croatia (Hrvatska)
  • Denmark
  • Greece
  • Hungary
  • Iceland
  • Israel
  • Italy
  • Lithuania
  • Poland
  • Romania
  • Slovakia
  • Slovenia
  • Thailand

Pasireotide diaspartate (a derivative of Pasireotide) is reported as an ingredient of Signifor in the following countries:

  • Austria
  • Finland
  • France
  • Germany
  • Norway
  • Sweden
  • Switzerland
  • United Kingdom
  • United States

Pasireotide pamoate (a derivative of Pasireotide) is reported as an ingredient of Signifor in the following countries:

  • France
  • Germany

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide